ArticleMolecular cancer therapeutics2011

Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma.

Osman Cen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.